Our Medical School by the numbers
The first successful open heart surgery. The first external pacemaker. The first pancreas transplant to cure diabetes.
Our University didn't just have a front row seat to these discoveries - our experts played the starring role, making each advancement possible.
And we didn't just stop there. We have a long history of changing the way patient care is delivered, and continually improving the way we teach the health care experts of the future.
For more than 120 years, the University of Minnesota has educated our state's future doctors and made discoveries in diseases including cancer, diabetes, and heart and brain diseases.
A tradition of firsts
The University of Minnesota Medical School has a long legacy of medical accomplishment that have improved the lives of people all over the world. Just a few highlights include:
Our biomedical breakthroughs have helped build Minnesota's thriving bioscience industry, and the work we do today continues to provide jobs and a venue to bring our discoveries to market.
Creating a world-class Medical School
The University of Minnesota Medical School held its first classes in 1888, after three of the four private medical schools in Minneapolis Saint Paul offered their charters and resources to the state.
In 1905, the estate of Augustus F. Elliot gave money to the University to open its first hospital. And so began the Medical School's long tradition of clinical partnerships, with the opening of the Elliot Memorial Hospital in 1911. Over the decades, private gifts led to the construction of more than a dozen medical buildings, clinics and hospitals on campus.
About Dean Friedman
Dr. Aaron Friedman is vice president for health sciences and dean of the University's Medical School, a role he assumed in January 2011.
Prior to his current role, Friedman was head of the Department of Pediatrics, holding the Ruben-Bentson Chair since his arrival to the Medical School in 2008.
"The University of Minnesota has a long history of leadership across the health sciences," Friedman said. "There is a remarkable amount of talent and resources here, at both a faculty and staff level - and even at a facilities level. This University has a wonderful track record and a great legacy, and I look forward to helping this institution ensure that both continue in the years ahead."
A pediatric nephrologist and dedicated educator, Friedman conducts research on pediatric kidney disease. He examines treatments aimed at preventing kidney failure in children with certain forms of kidney disease at the University of Minnesota Amplatz Children's Hospital. The University's children's hospital is a leader in pediatric kidney transplantation in the world and has one of the best infant kidney transplant success rates in the world.
In addition to his role within the Medical School, Friedman was pediatrician-in-chief at the University of Minnesota Amplatz Children's Hospital, a role he previously held at the Hasbro Children's Hospital/Rhode Island Hospital.
Outside of the University, Friedman is a member of the board of directors of the American Board of Pediatrics, serving as chair in 2008, and is active in the American Academy of Pediatrics. His research and scholarly work have centered on amino acid transport and factors influencing growth in chronic renal failure, and he serves as chair of a steering committee for an NIH-sponsored clinical trial in pediatric nephrology.
University of Minnesota Medical School
Subscribe to the subject University of Minnesota Medical School